Although antibiotics are clearly recognized as having a role in treating the infectious
complications of inflammatory bowel diseases (IBD), such as systemic sepsis and pelvic …

Inflammatory bowel disease is thought to be caused by an aberrant immune response to gut
bacteria in a genetically susceptible host. The gut microbiota plays an important role in the …

A growing amount of evidence indicates that the intestinal flora plays a pathogenic role in
inflammatory bowel disease (IBD): hence, the use of anti-bacterial agents as ancillary …

The etiology of inflammatory bowel disease (IBD) is unknown but may relate to an
unidentified bacterial pathogen or an immunological reaction to gut microbiota. Antibiotics …

The current model of pathogenesis for inflammatory bowel disease (IBD) is a dysregulated
immune system that is triggered by an environmental factor in a genetically susceptible …

Opinion statement Broad-spectrum antibiotics are the mainstay of therapy for patients with
Crohn's disease (CD) who present with localized peritonitis due to a microperforation …

An increasing amount of evidence suggests that enteric flora may have a role in the
pathogenesis of inflammatory bowel disease (IBD). Patients with IBD appear to have an …

There is abundant literature reporting about the use of antibiotics in inflammatory bowel
disease (IBD), but their role in the management of IBD is not entirely clear. Diverse infectious …

Inflammatory bowel diseases are characterized by an altered composition of gut microbiota
(dysbiosis) that may contribute to their development. Antibiotics can alter the bacterial flora …

Many experimental and clinical observations suggest that intestinal microflora plays a
potential role in the pathogenesis of inflammatory bowel disease (IBD). Manipulation of the …